Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Rapport Therapeutics, Inc. | Director | Common Stock | 20.4K | $204K | $9.99 | Sep 12, 2025 | Direct |
Tango Therapeutics, Inc. | Director | Common Stock | 5K | $42K | $8.39 | Jun 6, 2023 | Direct |
BELLICUM PHARMACEUTICALS, INC | Director | Stock Option (right to buy) | 15K | $21.6K | $1.44 | Jun 15, 2022 | Direct |
BELLICUM PHARMACEUTICALS, INC | Director | Common Stock | 147K | Jan 3, 2023 | Direct | ||
Tango Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 30K | Jun 6, 2023 | Direct | ||
Rapport Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 21.9K | Jun 17, 2025 | Direct | ||
CARGO Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | Aug 19, 2025 | Direct |